Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

US Patent 7820200 · Granted Oct 26, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Smart resource management for low latency use case2024
Methods and apparatus for transport protocol ACK aggregation2024
Active implantable medical device that can perform a frequential analysis2022
Active implantable medical device for nerve stimulation therapy with dynamic adj2022
Vibrotactile stimulation device2021
System comprising a probe for detecting a mass discharge of action potentials an2021
Device for discrimination of stages of a patient's sleep2019
System for respiratory disorder therapy with stabilization control of stimulatio2019
System for respiratory disorder therapy with selection of stimulation strategies2019
Device for optimization of sleep apnea syndrome therapy by kinesthetic stimulati2019
Device for the treatment of sleep apnea syndrome in a patient by kinesthetic sti2019
Active implantable medical device for heart failure treatment by stimulation of 2019